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Detection and Quantification of Glucuronidation of Ursolic Acid 
(UA) in Human Liver Microsomes (HLMs). 
Kamola Tolliboeva, Phillip M. Gerk; Department of Pharmaceutics
Your Name, Your Mentor’s NameAbstract
The purpose of this experiment was to establish and quantify the glucuronidation of ursolic 
acid (UA) in human liver microsomes (HLMs). We used three (100, 10, 1 uM) different UA 
concentrations incubated in 0.2 ug/uL HLMs for 1 hour. For each concentration of UA, we 
had an experimental (with UDPGA) and control group (without UDPGA). Aqueous 
samples were then treated with acetonitrile. Sample analysis was performed on a Cogent 
bidentate C18 column, with 90% methanol and 10% aqueous 10 mM ammonium acetate, 
and detection by electrospray mass spectrometry in negative ion mode ([M-H] = 455.3). 
The results confirmed the disappearance of UA in the presence but not absence of UDPGA.
Introduction
Ursolic acid (UA) is a lipophilic pentacyclic triterpenoid carboxylic acid that is widely 
found in food, herbs, fruits, and some medicines such as diabetic medications[1,2,3]. It is 
known to have range of biological activities such as serving as an antioxidant, anti-
inflammatory, and an antibacterial[3]. Current research on the properties of UA has shown 
its potential for use in obesity, glucose intolerance, fatty liver disease[1], and tumor and 
cancer prevention[3,4]. Clinical trials administering UA on human subjects are currently 
underway, therefore, it’s important to understand the metabolic process or 
glucuronidation of UA. Number of studies found the main UDP-glucuronosyltransferases 
(UGT) involved in the glucuronidation of UA were UGT1A3 and UGT1A4[3]. Based on 
the current research done on the metabolic mechanisms of UA, we hypothesize that UA 
is glucuronidated by HLMs as a source of UGT enzymes.
Results
The results of our experiment showed disappearance of UA after 1 
hour in the samples of the experimental group containing UDPGA 
compared to the control containing no UDPGA. This is consistent with 
glucuronidation of UA in the incubation mixture. 
Discussions
With numerous research studies pointing at the benefits of UA, many researchers 
are considering it as a potential therapeutic treatment for different diseases in 
humans. However, interaction of UA with metabolizing enzymes and other 
prescription drugs is largely unknown which creates several concerns regarding its 
administration to patients in clinical trials. In this experiment we were able to 
develop methods to establish the interaction of UA with UDPGA and UGT 
enzymes found in HLMs. We quantified the interaction by the peak height 
measured in uV indicating the disappearance of UA over time. Further refinement 
of these methods will help us understand how UA interacts with different UGT 
enzymes present in the human body (especially liver and intestine) allowing us to 
maximize its oral bioavailability and efficacy. 
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Methods
Figure 1: Glucuronidation of UA
Sample Name Time (mins) Height (uV)
1 uM experimental 1 262,035
1 uM control 1 262,214
1 uM experimental 60 165,437
1 uM control 60 230,565
1 uM UA 1 min experimental
1 uM UA 60 min control
1 uM UA 60 min experimental
1 uM UA 1 min control
Figure 2: UA remaining after glucuronidation 
Table 1: Quantification of Glucuronidation of UA
Additionally, we were able to quantify the glucuronidation of UA 
based on its peak height which showed gradual decrease with time 
indicating the loss of UA in the samples. 
Experimental and 
control groups were set 
up containing 3 
different concentrations 
(100, 10, 1 uM) of UA 
in 50 mM Tris HCl (pH 
7.4), 0.1mM 
saccharolactone, 10 mM 
MgCl2, 0.2 ug/uL 
HLMs, 0.03125 mg/mL 
alamethicin, and 
distilled water. 
The reactions were 
initiated with an addition 
of 2.5 mM UDPGA to 
samples in experimental 
group, and distilled water 
in the control group and 
incubated for 1 hour at 
37oC. 50 uL samples from 
3 concentrations of UA in 
both groups were 
collected at 1 and 60 
minutes.
Each sample was treated 
with of 200 uL of aceto-
nitrile, vortexed, and 
chilled on ice for 30 
minutes, after which they 
were centrifuged at 
maximum speed (17000 
RPM) and 4 oC for 10 
minutes.
Supernatants were 
transferred to HPLC vials 
and analysis was 
performed on a Cogent 
bidentate C18 column, 
with 90% methanol and 
10% aqueous 10 mM 
ammonium acetate, and 
detection by electrospray 
mass spectrometry in 
negative ion mode ([M-H] 
= 455.3).
